Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial (2023)

First Author: Liu X
Attributed to:  MRC Centre for Virus Research (MRC CVR) - COVID-19 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2023.04.012

Publication URI: http://dx.doi.org/10.1016/j.jinf.2023.04.012

Type: Journal Article/Review

Parent Publication: Journal of Infection

Issue: 1